These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12925654)

  • 1. Acute local reaction to intra-articular Hylan G-F 20 (Synvisc): part II.
    Waddell DD
    J Bone Joint Surg Am; 2003 Aug; 85(8):1620; author reply 1620-1. PubMed ID: 12925654
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute local reaction to intra-articular Hylan G-F 20 (Synvisc): part I.
    Magilavy D; Polisson R; Murray C
    J Bone Joint Surg Am; 2003 Aug; 85(8):1618-9; author reply 1619-20. PubMed ID: 12925653
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased frequency of acute local reaction to intra-articular Hylan G-F 20 (Synvisc) in patients receiving more than one course of treatment.
    Morton AH; Shannon P
    J Bone Joint Surg Am; 2003 Oct; 85(10):2050; author reply 2050-1. PubMed ID: 14563817
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment.
    Leopold SS; Warme WJ; Pettis PD; Shott S
    J Bone Joint Surg Am; 2002 Sep; 84(9):1619-23. PubMed ID: 12208919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute local reaction after intra-articular injection of HYALAN G-F 20 (Synvisc) for treatment of gonarthrosis onset].
    Oswald A; Gächter A
    Praxis (Bern 1994); 2000 Nov; 89(46):1929-31. PubMed ID: 11111412
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment.
    Goldberg VM; Coutts RD
    Clin Orthop Relat Res; 2004 Feb; (419):130-7. PubMed ID: 15021143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis.
    Zhao H; Liu H; Liang X; Li Y; Wang J; Liu C
    BioDrugs; 2016 Oct; 30(5):387-396. PubMed ID: 27435213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment.
    Cubukçu D; Ardiç F; Karabulut N; Topuz O
    Clin Rheumatol; 2005 Aug; 24(4):336-41. PubMed ID: 15599642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute local reaction to intra-articular infiltration with synvisc (Hylan GF20). About two cases].
    Noáin E; Sáncez-Villares JJ; Lasanta PJ; González Arteaga FJ
    An Sist Sanit Navar; 2003; 26(2):283-5. PubMed ID: 12951623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up.
    Waddell DD; Cefalu CA; Bricker DC
    J Knee Surg; 2005 Jan; 18(1):7-15. PubMed ID: 15742592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review.
    Waddell DD; Bricker DC
    J Surg Orthop Adv; 2006; 15(1):53-9. PubMed ID: 16603113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.
    Raynauld JP; Goldsmith CH; Bellamy N; Torrance GW; Polisson R; Belovich D; Pericak D; Tugwell P
    Osteoarthritis Cartilage; 2005 Feb; 13(2):111-9. PubMed ID: 15694572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
    Kemper F; Gebhardt U; Meng T; Murray C
    Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial(®)) vs hylan G-F20 (Synvisc(®)) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study.
    Pavelka K; Uebelhart D
    Osteoarthritis Cartilage; 2011 Nov; 19(11):1294-300. PubMed ID: 21875678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee.
    Zardawi IM
    J Bone Joint Surg Am; 2003 Dec; 85(12):2484; author reply 2484-5. PubMed ID: 14668528
    [No Abstract]   [Full Text] [Related]  

  • 16. The tolerability of viscosupplementation: low incidence and clinical management of local adverse events.
    Waddell DD
    Curr Med Res Opin; 2003; 19(7):575-80. PubMed ID: 14626291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral symmetric inflammatory reaction to hylan G-F 20 injection.
    Martens PB
    Arthritis Rheum; 2001 Apr; 44(4):978-9. PubMed ID: 11315938
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute inflammation with induction of anaphylatoxin C5a and terminal complement complex C5b-9 associated with multiple intra-articular injections of hylan G-F 20: a case report.
    Dragomir CL; Scott JL; Perino G; Adler R; Fealy S; Goldring MB
    Osteoarthritis Cartilage; 2012 Jul; 20(7):791-5. PubMed ID: 22484575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-articular hyaluronans: a review of product-specific safety profiles.
    Hamburger MI; Lakhanpal S; Mooar PA; Oster D
    Semin Arthritis Rheum; 2003 Apr; 32(5):296-309. PubMed ID: 12701040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review.
    Espallargues M; Pons JM
    Int J Technol Assess Health Care; 2003; 19(1):41-56. PubMed ID: 12701938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.